Find the latest Penlon company news headlines and press releases here.
The Penlon ESO 2 Emergency Ventilator today received internationally recognised CE Mark approval for the treatment of COVID-19 patients
Tim Rance, Production Manager at Penlon, talks about the ESO 2 Emergency Ventilator, the VentilatorChallengeUK (VCUK) consortium and working at Penlon during the coronavirus pandemic.
Paul Merrick, Production Engineering Manager at Penlon, talks about the ESO 2 Emergency Ventilator, the VentilatorChallengeUK (VCUK) consortium and working at Penlon during the coronavirus pandemic.
The continuing story of Penlon, VentilatorChallengeUK and the ESO 2 Emergency Ventilator
VentilatorChallengeUK, the consortium of UK aerospace, automotive and medical businesses that has come together to produce at-scale medical ventilators for the NHS, today celebrates two-months since it was formed.
The UK Government has ordered 15,000 Penlon ESO 2 Emergency Ventilators, the first device in the Ventilator Challenge to receive regulatory approval
Penlon ESO 2 Emergency Ventilators have arrived at NHS Nightingale Hospitals in London and Bristol.
NHS Nightingale Hospital London opens with 85 Penlon Anaesthetic Machines and a further 55 machines being delivered to other London hospitals. A further 20 will be delivered this week.
For customers that are considering using Penlon anaesthetic machines for treatment of patients with COVID-19
Penlon is currently working as part of a national drive to produce ventilators for the NHS.
A consortium of significant UK industrial, technology and engineering businesses from across the aerospace, automotive and medical sectors, has come together to produce medical ventilators for the UK.
UPDATE 30/3/20: At the request of the UK Government, Penlon is currently working as part of a national drive to produce ventilators for the NHS based on Penlon’s ESO2 system. We will of course continue to support other countries with their efforts to design, manufacture and assemble their own medical ventilators where we can.